Alternatives to Joint Surgery in West Valley City, UT

CDC PLACES vs. JF: two files, not one brochure

Adult arthritis here is 20.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 10.6% of adults in West Valley City have diagnosed diabetes — 1.4 points below the U.S. 12% figure. Together those PLACES numbers are why a city under 250k still needs separate PRP and CTP protocols. joint pain alternatives to surgery inventory is national; utilization is JF-local.

Where West Valley City programs actually stall

• Adult arthritis here is 20.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 19.8% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in Utah.
• A city under 250k of 140,230 residents sits against a U.S. diabetes prevalence of 12% (40.1 million people, CDC 2023). Diabetic foot-ulcer and chronic-wound programs need product plus LCD-aligned notes, not another catalog.
• Utah is outside CDC's historical Diabetes Belt core, but the national 12% diabetes figure still applies as a planning baseline until a clinic uses its own payer mix. Clinics asking for regenerative inventory still have to separate HCT/P 361 homologous-use products from unapproved “stem cell” claims (FDA 21 CFR 1271).

Payer geography for West Valley City, UT

JF reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in West Valley City is 10.6% or not. PLACES is planning data. The LCD is the claim.

How we’d stand this up in clinic